MetLife Investment Management’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.84M | Buy |
89,529
+7,257
| +9% | +$166K | 0.01% | 1209 |
|
|
2026
Q1 | $1.81M | Buy |
82,272
+1,973
| +2% | +$34.3K | 0.01% | 1112 |
|
|
2025
Q4 | $947K | Sell |
80,299
-9,892
| -11% | -$127K | ﹤0.01% | 1461 |
|
|
2025
Q3 | $1.43M | Hold |
90,191
| – | – | 0.01% | 1261 |
|
|
2025
Q2 | $1.03M | Buy |
90,191
+87,031
| +2,754% | +$981K | 0.01% | 1296 |
|
|
2025
Q1 | $42.8K | Sell |
3,160
-81,543
| -96% | -$1.35M | ﹤0.01% | 2703 |
|
|
2024
Q4 | $1.43M | Buy |
84,703
+7,055
| +9% | +$137K | 0.01% | 1237 |
|
|
2024
Q3 | $1.58M | Sell |
77,648
-1,271
| -2% | -$26K | 0.01% | 1146 |
|
|
2024
Q2 | $1.78M | Sell |
78,919
-2,634
| -3% | -$69K | 0.01% | 1029 |
|
|
2024
Q1 | $2.14M | Sell |
81,553
-2,150
| -3% | -$61.3K | 0.01% | 924 |
|
|
2023
Q4 | $2.64M | Sell |
83,703
-1,169
| -1% | -$31.7K | 0.02% | 821 |
|
|
2023
Q3 | $2.38M | Sell |
84,872
-4,505
| -5% | -$155K | 0.02% | 825 |
|
|
2023
Q2 | $3.3M | Sell |
89,377
-5,102
| -5% | -$156K | 0.02% | 706 |
|
|
2023
Q1 | $2.83M | Sell |
94,479
-4,112
| -4% | -$135K | 0.02% | 770 |
|
|
2022
Q4 | $3.02M | Sell |
98,591
-4,884
| -5% | -$147K | 0.02% | 727 |
|
|
2022
Q3 | $2.55M | Sell |
103,475
-1,414
| -1% | -$46.6K | 0.02% | 767 |
|
|
2022
Q2 | $3.36M | Sell |
104,889
-2,244
| -2% | -$82.5K | 0.03% | 661 |
|
|
2022
Q1 | $3.37M | Buy |
107,133
+28,160
| +36% | +$881K | 0.02% | 758 |
|
|
2021
Q4 | $2.65M | Sell |
78,973
-373
| -0.5% | -$11.6K | 0.02% | 740 |
|
|
2021
Q3 | $2.31M | Sell |
79,346
-3,363
| -4% | -$109K | 0.02% | 795 |
|
|
2021
Q2 | $2.88M | Sell |
82,709
-2,609
| -3% | -$86.4K | 0.03% | 700 |
|
|
2021
Q1 | $2.38M | Sell |
85,318
-4,696
| -5% | -$125K | 0.02% | 800 |
|
|
2020
Q4 | $2.23M | Sell |
90,014
-4,020
| -4% | -$95.6K | 0.02% | 773 |
|
|
2020
Q3 | $1.97M | Sell |
94,034
-3,487
| -4% | -$67.3K | 0.02% | 730 |
|
|
2020
Q2 | $1.5M | Buy |
97,521
+3,670
| +4% | +$46.4K | 0.02% | 847 |
|
|
2020
Q1 | $832K | Hold |
93,851
| – | – | 0.01% | 979 |
|
|
2019
Q4 | $1.7M | Sell |
93,851
-1,234
| -1% | -$20.5K | 0.02% | 869 |
|
|
2019
Q3 | $1.42M | Sell |
95,085
-2,057
| -2% | -$33.5K | 0.02% | 911 |
|
|
2019
Q2 | $2.33M | Sell |
97,142
-208,342
| -68% | -$6.14M | 0.02% | 743 |
|
|
2019
Q1 | $11.4M | Buy |
305,484
+201,162
| +193% | +$7.32M | 0.03% | 476 |
|
|
2018
Q4 | $2.94M | Sell |
104,322
-3,950
| -4% | -$125K | 0.04% | 556 |
|
|
2018
Q3 | $4.27M | Sell |
108,272
-3,545
| -3% | -$155K | 0.04% | 437 |
|
|
2018
Q2 | $4.96M | Sell |
111,817
-3,735
| -3% | -$186K | 0.06% | 310 |
|
|
2018
Q1 | $5.63M | Sell |
115,552
-1,602
| -1% | -$80.1K | 0.07% | 281 |
|
|
2017
Q4 | $5.87M | Buy |
+117,154
| New | +$6.14M | 0.07% | 281 |
|
Other funds holding CC
CCPM
MetLife Investment Management's CC Position: Q2 2026 in Review
MetLife Investment Management increased its Chemours (CC) stake by 8.8% in Q2 2026, buying an estimated $166K and bringing the position to 89,529 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #1209.
MetLife Investment Management first reported a position in CC in Q4 2017 and has held it in 35 quarters since. The position peaked at $11.4M in Q1 2019. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- MetLife Investment Management held 89,529 shares of Chemours worth $1.84M as of Q2 2026.
- MetLife Investment Management bought 7,257 Chemours shares in Q2 2026, an estimated $166K.
- Chemours made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1209 holding.
- MetLife Investment Management first reported a position in Chemours in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Chemours position peaked at $11.4M in Q1 2019.
- 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.